USA

Trial shows Enriched Omega-3 Chicken reduces heart attack risk

Poultry

The regular consumption of naturally enriched omega-3 chicken and eggs is likely to reduce risk of heart attack, stroke, dementia and depression, according to clinical trial delivered by the Royal College of Surgeons in Ireland, on behalf of farming and food company Devenish.

Posted on Nov 16 ,14:11

Trial shows Enriched Omega-3 Chicken reduces heart attack risk

 

The clinical trial involved 161 subjects which consumed at least three portions of chickens and eggs per week, that were naturally enriched with omega-3 Polyunsaturated Fatty Acids (PUFA), the same nutrients found in oily fish.

The results of the study showed an increase in omega-3-PUFA levels in blood and a positive shift in what is described as the 'omega-3 Index'-a test that measures the amount of the omega-3 fatty acids, Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) in red blood cell membranes, which reflects the levels in your heart and other tissues.

A low omega-3 Index (<4%) indicates a heightened risk of heart and brain disease. The study showed that consuming omega-3 enriched chicken and eggs resulted in a halving of the number of subjects with such a high-risk omega-3 Index.

The chicken meat and eggs used in the study came from birds offered OmegaPro, a sustainable and algae-based source of omega-3 PUFA, developed by Devenish.

"Greater consumption of oily fish has long been linked to a reduced incidence of heart attack, stroke, diabetes and cancer and improved brain health, vision, muscle and joint health," said Professor Alice Stanton of The Royal College of Surgeons in Ireland.

"International guidelines recommend eating oily fish at least once per week, however, many people do not eat fish at all and less than 20% of the world's population have optimal omega-3 PUFA levels," Professor Stanton added.

Furthermore, Owen Brennan, Executive Chairman, Devenish, added:

"We worked closely with Moy Park, Waitrose and the Royal College of Surgeons in Ireland, to deliver an innovative, nutrient-rich food, that increases omega-3 levels in consumers, naturally. The science shows the importance of food nutrients to promote good health in consumers and the innovation starts on the farm."

The results of the novel 6-month clinical trial were presented on a world stage at the American Heart Association Scientific Sessions Conference in Anaheim, California, on 14th November 2017.

Photo: Professor Alice Stanton of the Royal College of Surgeons in Ireland who delivered the world-first clinical trial on behalf of Devenish

 NEWSLETTER - Stay informed with the latest news!

Comments





Similar articles

BRAZIL

JBS multiplies its fleet of electric trucks by 7 and avoids the emission of 5.2 thousand tons of CO₂

This number is equivalent to the annual CO2 absorption of 237 thousand adult trees or 1,080 trips...


Read more Read more
EU

Development of alternative proteins: from a growth topic to a separate product area within IFFA

The trade fair is now picking up on this growth and dedicating a separate area to alternative pro...


Read more Read more
AUSTRALIA

Australia: TEKFARM brings tech to the farm

Managed by Farmers2Founders and supported by Meat & Livestock Australia (MLA), the ...


Read more Read more
Websolutions by Angular Software and SpiderClass